Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 3729401, 7 pages
https://doi.org/10.1155/2017/3729401
Research Article

Pattern and Appropriateness of Medicines Prescribed to Outpatients at a University Hospital in Northwestern Ethiopia

1Department of Pharmaceutics and Social Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia
2Department of Clinical Pharmacy, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia
3Department of Pharmacology, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia
4Research Center for Generational Health and Ageing, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia
5Department of Pharmaceutics, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia

Correspondence should be addressed to Fitsum Sebsibe Teni; moc.liamg@4estif

Received 18 July 2017; Accepted 26 November 2017; Published 18 December 2017

Academic Editor: Kurt G. Naber

Copyright © 2017 Fitsum Sebsibe Teni et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. IMS Institute for Healthcare Informatics, Outlook and Implications on Pharmaceuticals and Global Medicine, 2015, http://www.imshealth.com/en/thought-leadership/ims-institute/reports/global-medicines-use-in-2020.
  2. United Nations, “Access to affordable essential medicines,” WHO | Delivering on the Global Partnership for achieving the Millennium Development Goals. MDG Gap Task Force Report, MDG Gap Task Force Report, 2008. View at Google Scholar
  3. S. H. Masters, R. Burstein, B. Decenso et al., “Pharmaceutical availability across levels of care: Evidence from facility surveys in Ghana, Kenya, and Uganda,” PLoS ONE, vol. 9, no. 12, Article ID e0114762, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. World Health Organization, “Guide to Good Prescribing - A Practical Manual,” http://apps.who.int/medicinedocs/en/d/Jwhozip23e/.
  5. M. Pollock, O. V. Bazaldua, and A. E. Dobbie, “Appropriate prescribing of medications: an eight-step approach,” American Family Physician, vol. 75, no. 2, pp. 231–236, 2007. View at Google Scholar · View at Scopus
  6. R. Ofori-Asenso, P. Brhlikova, and A. M. Pollock, “Prescribing indicators at primary health care centers within the WHO African region: A systematic analysis (1995-2015),” BMC Public Health, vol. 16, no. 1, article no. 724, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. P. S. Patel, D. A. Rana, J. V. Suthar, S. D. Malhotra, and V. J. Patel, “A study of potential adverse drug-drug interactions among prescribed drugs in medicine outpatient department of a tertiary care teaching hospital,” Journal of Basic and Clinical Pharmacy, vol. 5, no. 2, pp. 44–48, 2014. View at Google Scholar
  8. D. Rathish, S. Bahini, T. Sivakumar et al., “Drug utilization, prescription errors and potential drug-drug interactions: An experience in rural Sri Lanka,” BMC Pharmacology & Toxicology, vol. 17, no. 1, article no. 27, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. J. M. Cruciol-Souza and J. C. Thomson, “Prevalence of potential drug-drug interactions and its associated factors in a Brazilian teaching hospital,” J. Pharm. Pharm. Sci, vol. 9, no. 3, pp. 427–433, 2006. View at Google Scholar
  10. E. Tragni, M. Casula, V. Pieri et al., “Prevalence of the prescription of potentially interacting drugs,” PLoS ONE, vol. 8, no. 10, Article ID e78827, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Ewen, W. Kaplan, T. Gedif et al., “Prices and availability of locally produced and imported medicines in Ethiopia and Tanzania,” Journal of Pharmaceutical Policy and Practice, vol. 10, no. 1, article no. 7, 2017. View at Publisher · View at Google Scholar · View at Scopus
  12. B. S. Carasso, M. Lagarde, A. Tesfaye, and N. Palmer, “Availability of essential medicines in Ethiopia: An efficiency-equity trade-off?” Tropical Medicine & International Health, vol. 14, no. 11, pp. 1394–1400, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Sado and A. Sufa, “Availability and affordability of essential medicines for children in the Western part of Ethiopia: Implication for access,” BMC Pediatrics, vol. 16, no. 1, article no. 40, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. Z. Desta, T. Abula, A. Gebre-Yohannes, and A. Worku, “Drug prescribing patterns for outpatients in three hospitals in north-west Ethiopia,” Ethiopian Journal of Health Development, vol. 16, no. 2, 2002. View at Publisher · View at Google Scholar
  15. A. I. Bilal, E. D. Osman, and A. Mulugeta, “Assessment of medicines use pattern using world health organization's prescribing, patient care and health facility indicators in selected health facilities in eastern Ethiopia,” BMC Health Services Research, vol. 16, no. 1, article no. 1414, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Sisay, J. Abdela, Z. Kano, M. Araya, M. Chemdi, and A. Fiseha, “Drug prescribing and dispensing practices in tertiary care hospital of eastern ethiopia: evaluation with world health organization core prescribing and patient care indicators,” Clinical & Experimental Pharmacology, vol. 07, no. 03, 2017. View at Publisher · View at Google Scholar
  17. M. Sisay, G. Mengistu, B. Molla, F. Amare, and T. Gabriel, “Evaluation of rational drug use based on World Health Organization core drug use indicators in selected public hospitals of eastern Ethiopia: A cross sectional study,” BMC Health Services Research, vol. 17, no. 1, article no. 161, 2017. View at Publisher · View at Google Scholar · View at Scopus
  18. T. S. Summoro, K. D. Gidebo, Z. Z. Kanche, and E. W. Woticha, “Evaluation of trends of drug-prescribing patterns based on WHO prescribing indicators at outpatient departments of four hospitals in southern Ethiopia,” Drug Design, Development and Therapy, vol. 9, pp. 4551–4557, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. K. D. Gidebo, T. S. Summoro, Z. Z. Kanche, and E. W. Woticha, “Assessment of drug use patterns in terms of the WHO patient-care and facility indicators at four hospitals in Southern Ethiopia: a cross-sectional study,” BMC Health Services Research, vol. 16, no. 1, pp. 1–8, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Gunasekaran, N. Dejene, V. V. Satyaveni, and M. D. Dhanaraju, “Occurrence of drug–drug interactions in Adama Referral Hospital, Adama city, Ethiopia,” Journal of Drug Assessment, vol. 4, no. 1, pp. 19–23, 2015. View at Publisher · View at Google Scholar
  21. B. Srikanth, E. Admassie, W. Hailu, T. Melese, and W. Mequanent, “Extent of poly-pharmacy, occurrence and associated factors of drug-drug interaction and potential adverse drug reactions in Gondar Teaching Referral Hospital, North West Ethiopia,” Journal of Advanced Pharmaceutical Technology & Research, vol. 4, no. 4, p. 183, 2013. View at Publisher · View at Google Scholar
  22. A. S. Bhagavathula, A. Berhanie, H. Tigistu et al., “Prevalence of potential drug-drug interactions among internal medicine ward in University of Gondar Teaching Hospital, Ethiopia,” Asian Pacific Journal of Tropical Biomedicine, vol. 4, pp. S204–S208, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Teka, G. Teklay, E. Ayalew, and T. Teshome, “Potential drug-drug interactions among elderly patients admitted to medical ward of Ayder Referral Hospital, Northern Ethiopia: A cross sectional study,” BMC Research Notes, vol. 9, no. 1, article no. 431, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Getachew, M. Assen, F. Dula, and A. S. Bhagavathula, “Potential drug-drug interactions in pediatric wards of Gondar University Hospital, Ethiopia: A cross sectional study,” Asian Pacific Journal of Tropical Biomedicine, vol. 6, no. 6, pp. 534–538, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. S. K. Lwanga, S. Lemeshow, and W. H. Organization, Sample size determination in health studies?: a practical manual, Dťermination de la taille d’ un čhantillon dans les ťudes sanomťriques, manuel pratique, 1991.
  26. WHO, “Sampling methods and sample size,” in Health Research Methodology: A Guide for Training in Research Methods, p. 77, WHO Regional Office for the Western Pacific, Manila, 2nd edition, 2001. View at Google Scholar
  27. Exchange Rates UK, Ethiopian Birr (ETB) to US Dollar (USD) exchange rate history, http://www.exchangerates.org.uk/ETB-USD-exchange-rate-history-full.html.
  28. WHO Collaborating Centre for Drug Statistics Methodology, “Guidelines for ATC classification and DDD assignment 2017,” https://www.whocc.no/atc_ddd_index_and_guidelines/guidelines/.
  29. Wage Indicator Foundation, “Minimum Wages in Ethiopia with effect from 01-01-2011,” http://www.wageindicator.org/main/salary/minimum-wage/ethiopia.
  30. Medscape, “Multi-Drug Interaction Checker,” http://reference.medscape.com/drug-interactionchecker.
  31. A. Isah, D. Ross-Degnan, J. Quick, R. Laing, and A. Mabadeje, “The development of standard values for the WHO,” http://archives.who.int/icium/icium/posters/1a2_txt.html.
  32. A. A. Desalegn, “Assessment of drug use pattern using WHO prescribing indicators at Hawassa University teaching and referral hospital, south Ethiopia: A cross-sectional study,” BMC Health Services Research, vol. 13, no. 1, article no. 170, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Wang, N. Li, H. Zhu, S. Xu, H. Lu, and Z. Feng, “Prescription Pattern and Its Influencing Factors in Chinese County Hospitals: A Retrospective Cross-Sectional Study,” PLoS ONE, vol. 8, no. 5, Article ID e63225, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. I. Tamuno and J. O. Fadare, “Drug prescription pattern in a Nigerian Tertiary hospital,” Tropical Journal of Pharmaceutical Research, vol. 11, no. 1, pp. 146–152, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Mahmood, A. A. Elnour, A. A. A. Ali, N. A. G. M. Hassan, A. Shehab, and A. S. Bhagavathula, “Evaluation of rational use of medicines (RUM) in four government hospitals in UAE,” Saudi Pharmaceutical Journal, vol. 24, no. 2, pp. 189–196, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. Institute for Health Metrics and Evaluation, “Ethiopia,” http://www.healthdata.org/ethiopia.
  37. The World Bank, “Poverty & Equity Data: Ethiopia,” http://povertydata.worldbank.org/poverty/country/ETH.
  38. Health Action Information Network, “A Survey on Medicine Prices and Availability in the Philippines,” 2009, http://haiweb.org/wp-content/uploads/2015/07/A-Survey-on-Medicine-Prices-and-Availability-in-the-Philippines.pdf.
  39. M. Bailey, “Affordability of Medicines,” 2004, http://apps.who.int/medicinedocs/en/d/Js18394en/.
  40. J. E. Lafata, L. Schultz, J. Simpkins et al., “Potential drugg-drug interactions in the outpatient setting,” Medical Care, vol. 44, no. 6, pp. 534–541, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. B. Nikolic, S. Jankovic, O. Stojanov, and J. Popovic, “Prevalence and predictors of potential drug-drug interactions,” Central European Journal of Medicine, vol. 9, no. 2, pp. 348–356, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. P. R. O. Neto, A. Nobili, S. Marusic et al., “Prevalence and predictors of potential drug-drug interactions in the elderly: a cross-sectional study in the Brazilian primary public health system,” Journal of Pharmacy & Pharmaceutical Sciences, vol. 15, no. 2, pp. 344–354, 2012. View at Publisher · View at Google Scholar · View at Scopus